Merck KGaA has agreed to acquire life sciences company Bio-Techne Corporation for $11.3bn, representing one of the largest financi...
Merck & Co (MSD) has signed a multi-year research collaboration with Quotient Therapeutics to discover new drug targets for in...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1), Ast...